danicamtiv (MYK-491) - BMS
"Carolyn Ho on new advances on HCM Excellent review in the molecular basis of HCM, on current treatments, on novel therapies (mavacamtem) and on how myosin modulation can be applied for dilated cardiomypathy (MYK-491) @CVCTForum #CVCT2020" (@SantosGallegoMD) Dec 5, 2020 
https://twitter.com/SantosGallegoMD/status/1335250452217262080
 
Dec 5, 2020
 
 
c405f03a-4e10-4378-9554-c56b82108e3a.jpg

ae1191e2-b6a4-41c2-8470-64eb0586cd65.jpg

500ff193-50ea-45c3-bd3a-6f21d24dc512.jpg

59be389e-22de-4205-a674-d97e190b760d.jpg